SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Fund Management Regulatory News (JUP)

Share Price Information for Jupiter Fund Management (JUP)

Share Price is delayed by 15 minutes
Get Live Data
176.00    5.60 (3.29%)
Bid:
176.00
Ask:
176.60
Spread: 0.60 (0.341%)
Market Cap: £883.48m
JUP Live PriceLast checked at - London Stock Exchange

Intraday Jupiter Fund Management Share Chart

Stabilisation Notice

22 Apr 2020 09:45

RNS Number : 4905K
J.P. Morgan Securities PLC.
22 April 2020
 

22 Apr 20

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Jupiter Fund Management plc

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Jupiter Fund Management plc

Guarantor (if any):

N/A

Aggregate nominal amount:

GBP tbc

Description:

GBP 10.25Y Non-Call 5Y Unsecured Unguaranteed Unsubordinated Tier 2 obligations of the Issuer

Listing: London Stock Exchange

Offer price:

TBC

Other offer terms:

Denoms: GBP 100,000 x GBP 1,000

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

 

Stabilisation period expected to start on:

22 Apr 20

Stabilisation period expected to end no later than:

22 May 20

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAEAPLAALDEEEA
Date   Source Headline
10th Jun 20263:15 pmRNSTransaction in Own Shares - Replacement
9th Jun 202612:15 pmRNSHolding(s) in Company
8th Jun 20264:00 pmRNSTransaction in Own Shares
2nd Jun 20265:19 pmRNSHolding(s) in Company
1st Jun 202611:00 amRNSTransaction in Own Shares
29th May 20265:15 pmRNSTotal Voting Rights
28th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20263:45 pmRNSTransaction in Own Shares
18th May 20263:30 pmRNSTransaction in Own Shares
11th May 20264:57 pmRNSTransaction in Own Shares
8th May 20264:00 pmRNSHolding(s) in Company
7th May 20263:30 pmRNSHolding(s) in Company
7th May 20261:00 pmRNSResult of AGM
5th May 20264:00 pmRNSTransaction in Own Shares
5th May 20263:00 pmRNSHolding(s) in Company
5th May 20262:45 pmRNSHolding(s) in Company
30th Apr 20265:00 pmRNSTotal Voting Rights
30th Apr 20262:45 pmRNSHolding(s) in Company
28th Apr 202612:45 pmRNSHolding(s) in Company
27th Apr 20264:02 pmRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTrading Update and Notice of Results
20th Apr 202612:20 pmRNSTransaction in Own Shares
14th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20261:00 pmRNSTransaction in Own Shares
8th Apr 20267:00 amRNSShare Buyback Programme
1st Apr 20263:00 pmRNSDirector/PDMR Shareholding
30th Mar 20263:00 pmRNSDirector/PDMR Shareholding
27th Mar 20263:30 pmRNSDirector/PDMR Shareholding
26th Mar 202612:12 pmRNSHolding(s) in Company
25th Mar 20264:51 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
24th Mar 20262:00 pmRNSAnnual Report and Accounts and Notice of AGM
18th Mar 20262:00 pmRNSHolding(s) in Company
4th Mar 202612:30 pmRNSHolding(s) in Company
4th Mar 202612:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:45 pmRNSDirector/PDMR Shareholding
27th Feb 20263:30 pmRNSDirector Shareholding
27th Feb 20263:15 pmRNSTotal Voting Rights
26th Feb 20265:00 pmRNSCancellation of Treasury Shares
26th Feb 20267:00 amRNSAnnual Financial Report
9th Feb 20263:45 pmRNSHolding(s) in Company
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
5th Feb 20262:42 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSHolding(s) in Company
2nd Feb 20261:30 pmRNSHolding(s) in Company
2nd Feb 20269:53 amRNSCompletion of Acquisition of CCLA
22nd Jan 20262:04 pmRNSHolding(s) in Company
7th Jan 20263:15 pmRNSHolding(s) in Company
31st Dec 202511:00 amRNSEntry into Forward Transaction for EBT
31st Dec 202511:00 amRNSEntry into Forward Transaction for EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.